Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)

BACKGROUND: Evidence about the efficacy and safety of statin treatment in high-risk patients with hypercholesterolemia is available for some populations, but not for ethnic Chinese. To test the hypothesis that treatment with pitavastatin (2 mg/day) is not inferior to treatment with atorvastatin (10...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ping-Yen, Lin, Liang-Yu, Lin, Hung-Ju, Hsia, Chien-Hsun, Hung, Yi-Ren, Yeh, Hung-I, Wu, Tao-Cheng, Chen, Ju-Yi, Chien, Kuo-Liong, Chen, Jaw-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788128/
https://www.ncbi.nlm.nih.gov/pubmed/24098467
http://dx.doi.org/10.1371/journal.pone.0076298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788128/
https://www.ncbi.nlm.nih.gov/pubmed/24098467
http://dx.doi.org/10.1371/journal.pone.0076298

Ejemplares similares